|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Pediatric Neuro-Oncology |
Division of Neurology and Oncology, Department of Pediatrics, Children's and Women's Hospital, Vancouver, BC V6H 3V4, Canada (J.H.); CNS Pfizer, Inc., New York, NY 10017 (J.S.); 3629 6th Avenue West, Seattle, WA 98119 (H.C.); Institute of Neurology and Neurosurgery, Beth Israel Medical Center, New York, NY 10128 (L.V., J.A.); and New York University Hospital, New York, NY 10016 (D.Z.); USA
1 Addresss correspondence to Juliette Hukin, K3, Neurology Division, Children's and Women's Hospital, 4480 Oak Street, Vancouver, BC V6H 3V4, Canada (jhukin{at}cw.bc.ca).
Abstract
The goal of this study was to describe the demographic, histologic, and prognostic features of children with low-grade neuroepithelial tumors (LGN) of the CNS presenting with leptomeningeal metastases (LM) at diagnosis. We identified 528 newly diagnosed LGN children, 13 (3%) of whom had LM at diagnosis. LM was defined by neuroimaging, clinical evidence, and/or biopsy. The charts were reviewed and patients contacted to validate the demographic data, treatment, and clinical status. The distribution of LM patients by primary tumor site was diencephalon, 5; cerebrum, 2; spinal cord, 3; brainstem, 2; and cerebellum, 1. Six of 8 patients with LM had durable objective responses to chemotherapy. The 5-year progression-free survival of patients with LM at diagnosis was 17%, compared to 85% (95% CI, 80%-91%) for those with localized LGN who had a gross total resection and 51% (95% CI, 44%-52%) for those with localized LGN who had less aggressive surgery (P < 0.0001). Only 1 of these 13 LM patients died. The 5-year overall survival of the localized LGN group with a gross total resection was 97% (95% CI, 92%-99.9%), and that of the localized LGN group with less aggressive surgery was 88% (95% CI, 84%-95%) (P = 0.004). The 3% frequency of LM at diagnosis is likely an underestimate since patients with newly diagnosed LGN were not routinely staged. We suggest that staging be considered in the following circumstances: diencephalic primary site, unexplained hydrocephalus, clinical features suggestive of LM, and before adjuvant therapy is initiated. The prognosis for children with LM at diagnosis is favorable, and its identification alters therapeutic strategies.
References
Akar, Z., Tanriover, N., Kafadar, A.M., Gazioglu, N., Oz, B., and Kuday, C. (2000) Chiasmatic low-grade glioma presenting with sacral intradural spinal metastasis. Childs Nerv. Syst. 16,309 -311.[CrossRef][Web of Science][Medline]
Bauman, G., Pahapill, P., Macdonald, D., Fisher, B., Leighton, C., and Cairncross, G. (1999) Low grade glioma: Measuring radiographic response to radiotherapy. Can. J. Neurol. Sci. 26,18 -22.[Web of Science][Medline]
Bourdon, M.A., Wikstrand, C.J., Furthmayer, H., Matthews, T.J., and
Bigner, D.D. (1983) Human glioma-mesenchymal extracellular matrix
antigen defined by monoclonal antibody. Cancer Res.
43,2796
-3805.
Brooks, P.C., Clark, R.A.F., and Cheresh, D.A. (1994)
Requirement of vascular integrin a/b3 for angiogenesis.
Science 264,569
-571.
Campbell, J.F., and Pollack, I. (1996) Cerebellar astrocytomas in children. J. Neurooncol. 28,223 -231.[CrossRef][Medline]
Cinalli, G., Sainte-Rose, C., Lellouch-Tubiana, A., Sebag, G., Renier, D., and Pierre-Kahn, A. (1995) Hydrocephalus associated with intramedullary low-grade glioma. Illustrative cases and review of the literature. J. Neurosurg. 83,480 -485.[Web of Science][Medline]
Civitello, L.A., Packer, R.J., Rorke, L.B., Siegel, K., Sutton,
L.N., and Schut, L. (1988) Leptomeningeal dissemination of
low-grade gliomas in childhood. Neurology
38,562
-566.
Claffey, K.P., and Robinson, G.S. (1996) Regulation of VEGF/VPF expression in tumour cells: Consequences for tumor growth and metastasis. Cancer Metastasis Rev. 15,165 -176.[CrossRef][Web of Science][Medline]
De Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N., and
Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor
for vascular endothe lial growth factor. Science
255,989
-991.
Di, X., Nishizaki, T., Harada, K., Kajiwara, K., Nakayama, H., and Ito, H. (1997) Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J. Exp. Clin. Cancer Res. 16,153 -157.[Web of Science][Medline]
Doireau, V., Grill, J., Zerah, M., Lellouch-Tubiana, A., and Couanet, D. (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumors in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP). Br. J. Cancer 81,835 -840.[CrossRef][Web of Science][Medline]
Edvardsen, K., Brunner, N., Spang-Thomsen, M., Walsh, F.S., and Bock, E. (1993) Migratory, invasive and metastatic capacity of NCAM transfected rat glioma cells. Int. J. Dev. Neurosci. 11,681 -690.[CrossRef][Web of Science][Medline]
Gajjar, A., Bhargava, R., Jenkins, J., Heideman, R., Sanford, R.A., Langston, J.W., Walter, A.W., Kuttesch, J.F., Muhlbauer, M., and Kun, L.E. (1995) Low grade astrocytoma with neuroaxis dissemination at diagnosis. J. Neurosurg 83, 67-71.[Web of Science][Medline]
Giannini, C., and Scheithauer, B.W. (1997) Classification and grading of low-grade astrocytic tumors in children. Brain Pathol. 7,785 -798.[Web of Science][Medline]
Giese, A., Loo, M.A., Tran, N., Haskett, D., Coons, S.W., and Berens, M.E. (1996) Dichotomy of astrocytoma migration and proliferation. Int. J. Cancer 67,275 -282.[CrossRef][Web of Science][Medline]
Hukin, J., Siffert, J., Velasquez, L., Zagzag, D., and Allen, J. (2002) Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors. Neuro-Oncol. 4, 253-260.[Abstract]
Jaworski, D.M., Kelly, G.M., Piepmeier, J.M., and Hockfield, S.
(1996) BEHAB (brain enriched hyaluronan binding) is expressed in
surgical samples of glioma and in intracranial grafts of invasive glioma cell
lines. Cancer Res. 56,2293
-2298.
Mamelak, A.N., Prados, M.D., Obana, W.G., Cogen, P.H., and Edwards, M.S.B. (1994) Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J. Neurosurg. 81, 24-30.[Web of Science][Medline]
McCowage, G., Tien, R., McLendon, R., Felsberg, G., Fuchs, H., Graham, M.L., Kurtzberg, J., Moghrabi, A., Ferrell, L., Kerby, T., Duncan-Brown, M., Stewart, E., Robertson, P.L., Colvin, O.M., Golembe, B., Bigner, D.D., and Friedman, H.S. (1996) Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med. Pediatr. Oncol. 27, 32-39.[CrossRef][Web of Science][Medline]
Packer, R.J., Ater, J., Allen, J., Phillips, P., Geyer, R., Nicholson, H.S., Jakacki, R., and Kurczynski, E. (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J. Neurosurg. 86,747 -754.[Web of Science][Medline]
Perilongo, G., Carollo, C., Salviati, L., Murgia, A., Pillon, M., Busso, G., Gardiman, M., and Laverda, A. (1997) Diencephalic syndrome and dis seminated juvenile pilocytic astrocytomas of the hypothalamic-optic chi asm region. Cancer 80,142 -146.[CrossRef][Web of Science][Medline]
Pollack, I.F., Hurtt, M., Pang, D., and Albright, A.L. (1994) Dissemination of low grade intracranial astrocytomas in children. Cancer 73,2869 -2878.[CrossRef][Web of Science][Medline]
Pollack, I.F., Claassen, D., Al-Shboul, Q., Janosky, J.E., and Deutsch, M. (1995) Low-grade gliomas of the cerebral hemispheres in children: An analysis of 71 cases. J. Neurosurg. 82,536 -547.[Web of Science][Medline]
Prados, M.D., Edwards, M.S.B., Rabbitt, J., Lamborn, K., Davis, R.L., and Levin, V.A. (1997) Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J. Neurooncol. 32,235 -241.[CrossRef][Medline]
Scott, E.W., and Mickle, J.P. (1987) Pediatric diencephalic gliomas - a review of 18 cases. Pediatr. Neurosci. 13,225 -232.[Web of Science][Medline]
Shapiro, K., and Shulman, K. (1976) Spinal cord seeding from cerebellar astrocytomas. Childs Brain 2, 177-186.[Web of Science][Medline]
Woo, S.Y., Donaldson, S.S., and Cox, R.S. (1988)
Astrocytoma in children: 14 years' experience at Stanford University Medical
Center. J. Clin. Oncol.
6,1001
-1007.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
